F, A., & N, D. (2016). LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: Current perspectives. Dove Medical Press.
Cita Chicago Style (17a ed.)F, Atashrazm, y Dzamko N. LRRK2 Inhibitors and Their Potential in the Treatment of Parkinson’s Disease: Current Perspectives. Dove Medical Press, 2016.
Cita MLA (8a ed.)F, Atashrazm, y Dzamko N. LRRK2 Inhibitors and Their Potential in the Treatment of Parkinson’s Disease: Current Perspectives. Dove Medical Press, 2016.
Precaución: Estas citas no son 100% exactas.